WEXFORD CAPITAL LP - 18 Aug 2026 Form 4 Insider Report for NEPHROS INC (NEPH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Aug 2026, 16:14:37 UTC
Prior SEC filing
22 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Wexford Capital LP, By: Wexford GP LLC, its general partner, By: Mark E. Ahern, Vice President and Assistant Secretary

Key filing fact

WEXFORD CAPITAL LP filed Form 4 for NEPHROS INC (NEPH) on 20 Aug 2026.

Key facts

  • This page summarizes WEXFORD CAPITAL LP's Form 4 filing for NEPHROS INC (NEPH).
  • 2 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2026, 16:14.

Change

  • Previous filing in this sequence was filed on 22 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (4)

CIK 0001048462 Primary reporting owner

WEXFORD CAPITAL LP

Relationship
10%+ Owner
Address
777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH
Signature
Wexford Capital LP, By: Wexford GP LLC, its general partner, By: Mark E. Ahern, Vice President and Assistant Secretary
Signature date
20 Aug 2026
CIK 0001472112

Wexford GP LLC

Relationship
10%+ Owner
Address
C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH
Signature
Wexford GP LLC, By: Mark E. Ahern, Vice President and Assistant Secretary
Signature date
20 Aug 2026
CIK 0001001391

DAVIDSON CHARLES E

Relationship
10%+ Owner
Address
C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH
Signature
Charles E. Davidson
Signature date
20 Aug 2026
CIK 0001048485

JACOBS JOSEPH

Relationship
10%+ Owner
Address
C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH
Signature
Joseph M. Jacobs
Signature date
20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEPH transaction

Common Stock

Options Exercise

Transaction value
Shares
+812
Change %
+1.4%
Price
$3.60*
Shares after
56,872
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1, F2
NEPH transaction

Common Stock

Options Exercise

Transaction value
Shares
+812
Change %
+1.4%
Price
$3.60*
Shares after
56,872
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1, F2
NEPH transaction

Common Stock

Options Exercise

Transaction value
Shares
+812
Change %
+1.4%
Price
$3.60*
Shares after
56,872
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1, F2
NEPH transaction

Common Stock

Options Exercise

Transaction value
Shares
+812
Change %
+1.4%
Price
$3.60*
Shares after
56,872
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEPH transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-3,765
Change %
-9.4%
Price
$0.000000*
Shares after
36,198
Date
18 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,765
Exercise price
$3.60
Footnotes
F3, F4
NEPH transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-3,765
Change %
-9.4%
Price
$0.000000*
Shares after
36,198
Date
18 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,765
Exercise price
$3.60
Footnotes
F3, F4
NEPH transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-3,765
Change %
-9.4%
Price
$0.000000*
Shares after
36,198
Date
18 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,765
Exercise price
$3.60
Footnotes
F3, F4
NEPH transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-3,765
Change %
-9.4%
Price
$0.000000*
Shares after
36,198
Date
18 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,765
Exercise price
$3.60
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the net number of shares of common stock issued upon the cashless exercise of stock options to purchase 3,765 shares, after a portion of the option shares was withheld to satisfy the exercise price.

Footnote F2

Includes shares of common stock granted to Wexford Capital LP ("Wexford Capital") as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.

Footnote F3

One-third of the options vested immediately upon the grant date of August 24, 2016. The remainder of the options vested in equal annual installments on each of the first and second anniversaries of the grant date.

Footnote F4

Includes stock options granted to Wexford Capital as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.

SEC remarks

Wexford GP LLC ("Wexford GP") may, as the General Partner of Wexford Capital, be deemed to own beneficially the securities held by Wexford Capital. Each of Charles E. Davidson ("Davidson") and Joseph M. Jacobs ("Jacobs", and together with Wexford Capital, Wexford GP and Davidson, the "Reporting Persons") may, by reason of his status as a controlling person of Wexford GP, be deemed to own beneficially the securities held by Wexford Capital. Each of Wexford Capital, Wexford GP, Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by Wexford Capital. Each of Wexford GP, Davidson and Jacobs disclaim beneficial ownership of the securities owned by Wexford Capital, as applicable, and this report shall not be deemed as an admission that they are the beneficial owners of such securities, except to the extent of any pecuniary interests therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .